HHealthcare Read More Novo Nordisk justifies reasoning behind failed GLP-1 Alzheimer’s trialsDecember 3, 2025 By Deena Beasley SAN DIEGO Dec 2 (Reuters) – Novo Nordisk in 2020 launched pivotal trials of its…
GGenetics Read More Dr. Juan Fortea discusses his groundbreaking research redefining APOE4 homozygosity as a genetic cause of Alzheimer’s and his upcoming webinarOctober 21, 2025 WASHINGTON, Oct. 21, 2025 /PRNewswire/ — APOE4 Alzheimer’s Alliance Board Member Perry S. Chen discusses Dr. Fortea’s groundbreaking…